| Residents-as KK Bree, SA Whicker, HB Fromme, S Paik, L Greenberg teachers publications: what can programs learn from the literature when …, 2014 | 60 | 2014 |
| Residents-as-teachers publications: what can programs learn from the literature when starting a new or refining an established curriculum? KK Bree, SA Whicker, HB Fromme, S Paik, L Greenberg Journal of Graduate Medical Education 6 (2), 237-248, 2014 | 42 | 2014 |
| Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non–muscle-invasive bladder cancer treated … N Lobo, PJ Hensley, KK Bree, GM Nogueras-Gonzalez, N Navai, ... European Urology Oncology 5 (1), 84-91, 2022 | 37 | 2022 |
| Management, surveillance patterns, and costs associated with low-grade papillary stage ta non–muscle-invasive bladder cancer among older adults, 2004-2013 KK Bree, Y Shan, PJ Hensley, N Lobo, C Hu, DS Tyler, K Chamie, ... JAMA network open 5 (3), e223050-e223050, 2022 | 30 | 2022 |
| Contemporary rates of gynecologic organ involvement in females with muscle invasive bladder cancer: a retrospective review of women undergoing radical cystectomy following … KK Bree, PJ Hensley, ME Westerman, A Kokorovic, ... The Journal of urology 206 (3), 577-585, 2021 | 23 | 2021 |
| Current therapy and emerging intravesical agents to treat non–muscle invasive bladder cancer KK Bree, NA Brooks, AM Kamat Hematology/Oncology Clinics 35 (3), 513-529, 2021 | 21 | 2021 |
| Sequential intravesical gemcitabine and docetaxel is an alternative to bacillus Calmette-Guérin for the treatment of intermediate-risk non–muscle-invasive bladder cancer WS Tan, IM McElree, F Davaro, RL Steinberg, K Bree, N Navai, ... European urology oncology 6 (5), 531-534, 2023 | 16 | 2023 |
| Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis F Ghali, AA Elbakry, ZA Hamilton, K Yim, R Nasseri, S Patel, A Eldefrawy, ... World journal of urology 38, 1113-1122, 2020 | 16 | 2020 |
| Apixaban vs enoxaparin for post-surgical extended-duration venous thromboembolic event prophylaxis: a prospective quality improvement study ME Westerman, KK Bree, P Msaouel, JB Kukreja, C Mantaring, I Rukundo, ... The Journal of urology 208 (4), 886-895, 2022 | 14 | 2022 |
| Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre N Lobo, KK Bree, PJ Hensley, GM Nogueras‐Gonzalez, P Abraham, ... BJU international 130 (3), 323-330, 2022 | 13 | 2022 |
| All high-grade Ta tumors should be classified as high risk: bacillus Calmette-Guérin response in high-grade Ta tumors KK Bree, PJ Hensley, N Lobo, NA Brooks, GM Nogueras-Gonzalez, ... The Journal of Urology 208 (2), 284-291, 2022 | 12 | 2022 |
| Progression of disease after bacillus Calmette-Guérin therapy: refining patient selection for neoadjuvant chemotherapy before radical cystectomy PJ Hensley, KK Bree, MT Campbell, O Alhalabi, A Kokorovic, T Miest, ... The Journal of Urology 206 (5), 1258-1267, 2021 | 11 | 2021 |
| What women want: radical cystectomy and perioperative sexual function educational needs ME Westerman, KK Bree, A Kokorovic, J Frank, XS Wang, AM Kamat, ... Urology 157, 181-187, 2021 | 11 | 2021 |
| Bladder-sparing treatment in patients with bacillus Calmette-Guerin–unresponsive non–muscle-invasive bladder cancer: an analysis of long-term survival outcomes WS Tan, V Grajales, R Contieri, P Hensley, K Bree, P Msaouel, CC Guo, ... European Urology Open Science 53, 16-22, 2023 | 9 | 2023 |
| Germline predisposition to prostate cancer in diverse populations KK Bree, PJ Hensley, CA Pettaway Urologic Clinics 48 (3), 411-423, 2021 | 9 | 2021 |
| Oncological outcomes for patients with European Association of Urology very high-risk non–muscle-invasive bladder cancer treated with bacillus Calmette-Guérin or early radical … R Contieri, PJ Hensley, WS Tan, V Grajales, K Bree, ... European Urology Oncology 6 (6), 590-596, 2023 | 8 | 2023 |
| Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response PJ Hensley, KK Bree, N Brooks, J Matulay, R Li, GM Nogueras Gonzalez, ... BJU international 128 (5), 634-641, 2021 | 8 | 2021 |
| Impact of age> 70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin R Contieri, V Grajales, WS Tan, A Martini, A Sood, P Hensley, K Bree, ... BJU international 133 (1), 63-70, 2024 | 6 | 2024 |
| Implications of guideline-based, risk-stratified restaging transurethral resection of high-grade Ta urothelial carcinoma on bacillus calmette-guérin therapy outcomes PJ Hensley, KK Bree, N Brooks, J Matulay, R Li, GM Nogueras-Gonzalez, ... European urology oncology 5 (3), 347-356, 2022 | 5 | 2022 |
| Germline mutations in African American men with prostate cancer: incidence, implications and diagnostic disparities KK Bree, PJ Hensley, CA Pettaway Urology 163, 148-155, 2022 | 5 | 2022 |
